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ABSTRACT
Mammalian base excision repair (BER) is mediated
through at least two subpathways designated
‘single-nucleotide’ (SN) and ‘long-patch’ (LP) BER
(2-nucleotides long/more repair patch). Two forms
of DNA substrate are generally used for in vitro BER
assays: oligonucleotide- and plasmid-based. For
plasmid-based BER assays, the availability of large
quantities of substrate DNA with a specific lesion
remains the limiting factor. Using sequence-specific
endonucleases that cleave only one strand of DNA
on a double-stranded DNA substrate, we prepared
large quantities of plasmid DNA with a specific
lesion. We compared the kinetic features of BER
using plasmid and oligonucleotide substrates con-
taining the same lesion and strategic restriction
sites around the lesion. The Km for plasmid DNA
substrate was slightly higher than that for the
oligonucleotide substrate, while the Vmax of BER
product formation for the plasmid and oligonucleo-
tide substrates was similar. The catalytic efficiency
of BER with the oligonucleotide substrate was
slightly higher than that with the plasmid substrate.
We conclude that there were no significant differ-
ences in the catalytic efficiency of in vitro BER
measured with plasmid and oligonucleotide sub-
strates. Analysis of the ratio of SN BER to LP BER
was addressed using cellular extracts and a novel
plasmid substrate.
INTRODUCTION
To understand cellular responses to endogenous genotoxic
stress, it is important to have insight into the DNA repair
process known as base excision repair (BER). BER is
involved in repairing base lesions and single-strand breaks
that occur thousands of times during the average
mammalian cell cycle (1–3) and is generally considered
to involve two subpathways deﬁned by the size of the
repair patch and the enzymes involved (4–7). These
subpathways are termed single-nucleotide (SN) BER and
long-patch (LP) BER. As these names imply, in SN BER
one nucleotide in the damaged strand is excised and
replaced (8–11), whereas LP BER excises and replaces
several nucleotides in the damaged strand (6,9). LP BER
appears to be a backup subpathway in cases where the SN
BER system stalls or where the DNA lesion is refractory
to the enzymatic steps of the SN BER subpathway
(6,9,12–14).
Components of the BER system are constitutively
expressed in mammalian cells, but also exhibit widely
divergent tissue-speciﬁc expression levels plus up- or
down-regulation after genotoxic stress and cytokine
exposure (15–20). This dynamic regulatory picture sug-
gests the potential for cell type speciﬁc diﬀerences in
cellular capacity for BER and also for diﬀerences in
relative use of the two BER subpathways, since there are
distinct enzymes and accessory factors involved in each
(4–7,10,21–25). Methods for characterization of the over-
all amount and eﬃciency of BER in vivo are limited, and
improved methods for quantitative measurement of repair
capacity and subpathway choice are needed for studies of
extract-mediated BER.
In recent years, research in the BER area has been
greatly facilitated through measurements of in vitro BER
activity using oligonucleotide and plasmid substrates
containing a lesion in a deﬁned site and sequence context
(4–6,8,10,26). There has been debate, however, on
advantages and disadvantages regarding the form of
DNA used as substrate, i.e. plasmid versus oligonucleo-
tide. For example, oligonucleotide substrates oﬀer the
advantage of relative ease of preparation of large amounts
of pure material, and hence the option of preparing
in vitro reaction mixtures with an excess of DNA
substrate. Under this condition, steady-state measure-
ments of repair activity of extracts can be obtained using
short incubation periods (e.g. 1min) and small amounts of
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plasmid substrate with the same lesion has involved
reaction mixtures with only minimal concentrations of
substrate DNA, in view of the diﬃculty of preparing large
quantities of plasmid material. This limitation imposes a
need for longer incubation periods with higher amounts of
protein extract, in order to observe conversion of a
signiﬁcant amount of substrate into product. Such
substrate-limiting, or eﬃciency-based, conditions can
complicate interpretation of reaction kinetics. In addition,
there are concerns regarding competing enzymatic activ-
ities such as nucleases, as well as plasmid substrate
impurities that reduce the eﬀective concentration of
substrate. Nevertheless, there can be advantages in using
plasmid substrate molecules. For example, artifacts due to
protein binding to DNA ends can be eliminated. Also
plasmids allow assembly of multi-protein complexes that
are too large to be accommodated on oligonucleotide
molecules. In addition, plasmids enable use of clamp
proteins requiring long and/or circular substrate molec-
ules, such as PCNA (23). Finally, there has been a
suggestion that plasmid DNA substrates are more relevant
to in vivo events than oligonucleotide substrate molecules,
however, this latter point has been controversial.
Resolution of this debate and uncertainties about choice
of substrate DNA can be facilitated by a direct
comparison of BER kinetics obtained with each type of
DNA bearing the same lesion and sequence context. This
comparison has been enabled recently by the introduction
of a method for plasmid DNA preparation that yields
large amounts of puriﬁed plasmid in a relatively short
period (26–30). In the present study, we examined cell
extract-mediated uracil-initiated BER using plasmid and
oligonucleotide substrates with the U:G mispair in the
same sequence context. Repair was measured under
steady-state conditions for each type of substrate. Values
for Km and Vmax were obtained using laboratory reference
extracts from bovine testis and mouse embryonic ﬁbro-
blasts (MEF). The results of these analyses indicated that
plasmid and oligonucleotide substrates yielded similar
Vmax values for uracil-DNA BER activity, although the
catalytic eﬃciency (Vmax/Km) of repair with the oligonu-
cleotide substrate was slightly higher than with the
plasmid substrate. Methods for measuring the ratio of
the two BER subpathways, SN BER and LP BER, and for
evaluation of the LP BER repair patch size are also
discussed.
MATERIALS AND METHODS
Materials
Synthetic oligodeoxyribonucleotides were from Integrated
DNA Technologies, Inc. (Coralville, IA, USA) and Oligos
Etc. Inc. (Wilsonville, OR, USA). The [a-
32P]dCTP and
dTTP (3000Ci/mmol) were from GE HealthCare
(Piscataway, NJ, USA). Pfu DNA polymerase was from
Stratagene (La Jolla, CA, USA). Endonuclease N.BstNB1,
T4 DNA ligase and all other restriction enzymes were from
New England Biolabs (Beverly, MA, USA). Plasmids were
isolated using Qiagen Plasmid Maxi kits from Qiagen
(Valencia, CA, USA). Streptavidin-coated magnetic beads
(Dynabeads M-280) were from Invitrogen (Carlsbad, CA,
USA). Recombinant human DNA polymerase b (Pol b)
was overexpressed and puriﬁed as described previously
(31). Human uracil-DNA glycosylase (UDG), apurinic/
apyrimidinic endonuclease (APE) and DNA ligase I were
puriﬁed as described previously (32–34).
Preparation of lesion-specific plasmid DNA substrates
Lesion-speciﬁc BER plasmid substrates were prepared
essentially as described previously (29) with slight
modiﬁcations. Plasmid pUC19N was derived from
pUC19 by inserting a 43-bp phosphorylated oligonucleo-
tide (50-GATCGAGTCGAATGCATGCCTCGAGTCT
A GAGGTACCAGATCT-30) at the BamHI site position
417. During this process the BamHI site was lost. The
resulting pUC19N contained two N.BstNB1 sites ﬂanking
48 bases that could be substituted with a lesion-speciﬁc
oligonucleotide. The sequence of the pUC19N plasmid
was conﬁrmed by sequencing. A 48-mer oligonucleotide in
the sense strand that contained a deﬁned lesion base
[uracil or tetrahydrofuran (THF) at position 20, under-
scored C above] was replaced between two N.BstNB1 sites
as follows: pUC19N (100mg, 57 pmol) was digested with
500U of N.BstNB1 at 558C for 2 to 3h, followed by
subsequent incubation with 200pmol 30-biotin-tagged
complementary 48-mer oligonucleotide on a rotary
shaker for 30min at 378C. Then, streptavidin-coated
Dynabeads M-280 (400pmol), pre-equilibrated with
10mM Tris–HCl, pH 7.5, 0.5mM EDTA and 1M
NaCl, were added to the reaction mixture, and the
mixture was incubated for 2h at 378C. The 48-bp biotin-
tagged DNA, adsorbed onto magnetic beads, was
separated from the gapped-pUC19N DNA by placing
the reaction mixture tube on a magnet for 2min to collect
the beads. The supernatant was carefully removed with a
pipette while the tube remained on the magnet. Gapped-
plasmid DNA in the supernatant was extracted twice with
phenol/chloroform and precipitated with 95% ethanol.
A 20-fold excess of uracil or THF lesion-containing
48-mer oligonucleotide (1.0nmol) was added to the
gapped-pUC19N DNA in 10mM Tris–HCl, pH 8.0 and
50mM NaCl. The DNA mixture was annealed at 458C for
4h, and then incubated at 258C for 15h with 5000U of T4
DNA ligase. In order to purify the closed-circular DNA
(ccDNA) plasmid from the un-ligated nicked DNA, two
rounds of isopycnic centrifugation in CsCl2 with ethidium
bromide were performed. The yield of lesion-speciﬁc
plasmid DNA was  30–50% of the starting plasmid
(i.e.  25pmol). The purity of each plasmid preparation
was evaluated by digestion with XhoI and subsequent
electrophoretic separation of ccDNA and linearized
DNA. In this assay, the starting plasmid, pUC19N
(plasmid without a lesion), was linearized by XhoI
digestion, whereas the lesion-speciﬁc substrates were not.
This test for contaminating starting plasmid was
considered an important precaution as contamination
with the starting plasmid was found to be signiﬁcant for
some preparations, owing to ineﬃcient removal of 48-mer
N.BstNB1 DNA fragment and religation in the last
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either uracil or THF were designated as pUN1 or pUN2,
respectively. Routinely, the ratio of lesion-speciﬁc plasmid
to starting plasmid was greater than 3:1 in the experi-
ments shown here.
Preparationoflesion-specificoligonucleotideDNAsubstrates
Unphosphorylated 55-mer oligonucleotide (100mM) with
30 inverted dT (50-TCGGTACCCGGGGATCGAGT
CGAATGCATGCCTCGAGTCTAGAGGTACCAGAT
CT-30) containing either uracil or THF at position 32
(underscored C) was annealed to its complementary
unphosphorylated 55-mer in 10mM Tris–HCl, pH 8.0
and 100mM NaCl, and then the DNA solution was
diluted to 1mM in the same buﬀer. The solution was
divided into aliquots and stored at  808C.
Preparation of lesion-specific pPAL1 plasmid
The plasmid pGL4.10TKKpn (5.0kb) was constructed
from pGL4.10 (Promega, Madison, WI, USA) by insert-
ing the TK promoter between KpnI and HindIII sites.
During this process the KpnI site was lost. For the in vitro
BER plasmid assay, pPAL1 was prepared by replacing the
HindIII-ApaI fragment of pGL4.10TKKpn with an
oligonucleotide that contained a uracil at a new KpnI
site and unique NcoI and SacI restriction sites.
To prepare the HindIII-ApaI fragment, pGL4.10TK
Kpn was digested with ApaI and subsequently treated
with calf intestine alkaline phosphatase. The resultant
plasmid was digested by HindIII and puriﬁed by 1%
agarose gel electrophoresis. Then a 73/81-bp hybrid
oligonucleotide was prepared by annealing unphosphory-
lated 73-mer 50CTTCTTAATGTTTTTGGCATCTTCC
ATGGTGGCTTTACCAAGGTAUCAGTAAGTATTA
ATTAAGGAGAGCTCA-30 and 50-phosphorylated
81-mer 50-AGCTTGAGCTCTCCTTAATTAATACTT
ACTGGTACCTTGGTAAAGCCACCATGGAAGATG
CCAAAAACATTAAGAAGGGCC-30 DNA. Ligation
of this oligonucleotide into the HindIII-ApaI digestion
product of pGL4.10TKKpn was carried out as
described (35). The closed circular DNA was separated
by 1% low-melting temperature agarose gel electrophor-
esis containing SYBR Gold nucleic acid gel stain
(Invitrogen), and the plasmid was recovered using a gel
extraction kit (Qiagen). The resulting plasmid, pPAL1,
was obtained in microgram quantities.
Nuclear extractpreparation
Nuclear extract was prepared from bovine testis essen-
tially as described previously (36). Brieﬂy, 100g of bovine
testis was minced in 300ml buﬀer A [10mM Hepes,
pH 8.0, 1.5mM MgCl2, 10mM NaCl, 0.5mM dithio-
threitol (DTT), 10mM sodium metabisulﬁte, 0.1mM
4-(2-aminoethyl)benzenesulfonylﬂuoride (AEBSF), 1mM
benzamidine, 1mg/ml leupeptin and 1mg/ml pepstatin A]
and homogenized using four 10s bursts with a blender at
48C. The homogenate was pelleted by centrifugation
at 10000 g for 10min at 48C. Pellet fraction was
resuspended in 150ml of buﬀer B (same as buﬀer A,
except it contained 1M NaCl) and blended using three
5s bursts. The homogenate was centrifuged at 100000 g
for 1h at 48C. The clear supernatant fraction was brought
to 40% saturation by adding solid ammonium sulfate
slowly with stirring; stirring was continued for 1h at 48C.
The precipitate was recovered by centrifugation at
14000 g for 20min at 48C. The pellet fraction was
resuspended in 50ml of buﬀer C (25mM Hepes, pH 7.5,
100mM NaCl, 1mM DTT, 10mM sodium metabisulﬁte,
0.5mM EDTA, 0.1mM AEBSF, 1mM benzamidine,
1mg/ml leupeptin, 1mg/ml pepstatin A and 20% glycerol)
and dialyzed against the same buﬀer. The dialyzed nuclear
extract was clariﬁed by centrifugation at 10000 g for
20min. The clear supernatant fraction was referred to as
the bovine testis nuclear extract (BTNE) and stored
at  808C. Protein concentration was determined with
a Bio-Rad protein assay kit using bovine serum albumin
(BSA) as a standard.
Cellextract preparation
Whole cell extract was prepared as previously
described (4). Brieﬂy, cells were washed twice with
phosphate-buﬀered saline at room temperature, detached
by scraping, pelleted by centrifugation and resuspended
in Buﬀer I (10mM Tris–HCl, pH 7.8, 200mM KCl
and protease inhibitor cocktail). An equal volume of
Buﬀer II (10mM Tris–HCl, pH 7.8, 200mM KCl,
2mM EDTA, 40% glycerol, 0.2% Nonidet P-40, 2mM
DTT and protease inhibitor cocktail) was added. The
suspension was rotated for 1h at 48C, and the resulting
extract was clariﬁed by centrifugation at 14000rpm
at 48C. The protein concentration of the extract was
determined as above, and aliquots were stored at  808C.
Invitro BER assay
Uracil- and THF-containing plasmids were designed as
described above to quantify total BER, SN BER and LP
BER in the same reaction. A 48-nt N.BstNB1 fragment
containing uracil or THF (Figure 1) was inserted in
pUC19, which upon digestion with strategic restriction
enzymes, as indicated in Figure 2, would generate frag-
ments representing total BER product (41-bp KpnI
fragment), SN BER plus LP BER (25-bp KpnI-XhoI
fragment) and LP BER (16-bp XhoI-KpnI fragment). BER
assays were performed using reaction mixtures of
10ml ﬁnal volume that contained 20–500nM plasmid or
oligonucleotide DNA substrate, 10mg of extract, 50mM
Tris–HCl, pH 7.5, 5mM MgCl2, 20mM NaCl, 1mM
DTT, 4mM ATP, 20mM each of dATP, dGTP and dTTP
or dCTP and 2.3mM[ a-
32P]dCTP or [a-
32P]dTTP,
as indicated. The incubation was at 378C for 1 to
30min, as indicated. Reactions were terminated by
adding 1ml of 0.5M EDTA and 90ml TE (10mM Tris–
HCl, pH 8.0 and 1mM EDTA), and this was followed
by phenol/chloroform extraction and ethanol precipita-
tion. To facilitate ethanol precipitation, 100ng of carrier
tRNA was added to each reaction mixture. The resulting
DNA pellet fraction was dissolved in H2O and divided
into three equal portions. These DNA-containing
portions were subjected to restriction enzyme digestion
as follows: (i) no enzyme, (ii) KpnI and (iii) KpnI plus
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at 378C. The resulting reaction products were separated
by 20% denaturing polyacrylamide gel electrophoresis
(PAGE). The gels were dried, scanned with a Typhoon
PhosphorImager and the data were analyzed with
ImageQuant software. The BER assay, with uracil-
containing plasmid, pPAL1, also was performed under
similar reaction conditions as above, and the repaired
DNA was restricted with NcoI/SacI and/or KpnI, as
indicated in Figure 5. The experiments were repeated
several times, and representative images and average
values of SN BER and LP BER are shown. In vitro
BER assays using the 55-bp oligonucleotide duplex DNA
and cellular extracts were performed under similar
reaction conditions as with the plasmid DNA.
RESULTS
Preparation ofplasmid DNA substrates
A plasmid DNA substrate containing either uracil or THF
opposite guanine was prepared as outlined in Figure 1.
Uracil opposite guanine was chosen because this mis-
match is a widely used initiating lesion for studies of
in vitro BER. The THF abasic site lesion was chosen as a
reference because all BER with this lesion occurs through
the LP BER subpathway, since DNA ligation after the
gap-ﬁlling step in BER is blocked by the persistent THF
group (12,13). A key feature in plasmid preparation was
the use of the single-strand cutting restriction enzyme
N.BstNB1, such that a single-strand gap of 48nt was
introduced into the plasmid and the released 48-mer was
removed (Figure 1, see penultimate step). Eventually, a
synthetic 48-mer uracil-containing or THF-containing
oligonucleotide was annealed into the gap, and the nicks
were ligated with good yield (Figure 1, ﬁnal step). The
plasmids (pUN1 or pUN2) thus prepared could be
puriﬁed in milligram quantities, enabling the use of as
much as micromolar ﬁnal concentrations of plasmid
substrate in BER reaction mixtures.
In addition, these plasmids were designed such that the
lesion was ﬂanked with two KpnI sites (Figure 2A).
Digestion of BER reaction products with this enzyme
yielded a 41-nt fragment (41-mer). Upon denaturing gel
electrophoresis, the incorporation of labeled dNMPs into
the repair patch within this fragment could be measured.
Quantitative assessment of the repair product formed
during the BER incubation could be obtained by double
digestion with KpnI and XhoI and use of
32P-labeled dCTP
as one of the nucleotide substrates. In this way,
incorporation of labeled dCMP into the ﬁrst dNMP
position of the repair patch was used to quantify the molar
amount of repair product formed. This digestion also
produced a 16-mer fragment corresponding to the second
through seventeenth incorporations by the LP BER sub-
pathway, and should contain most of the LP BER product
(Figure 2A). In some cases, KpnI digestion alone yielded a
25-nt (25-mer) labeled fragment reﬂecting accumulation of
stalled/unligated BER intermediate, i.e. intermediate prior
to the DNA ligation step in SN BER or the strand
displacement step in LP BER. In the experiments shown
subsequently, this material was considered as background
since it did not represent complete repair. Digestion with
other restriction enzymes is also illustrated in Figure 2.
Two fragments are produced by double digestion with
XhoI and XbaI, a 6-mer representing the second through
seventh incorporations in the repair patch and a 23-mer
representing incorporations out to the 30th position in the
repair patch (Figure 2A).
With the oligonucleotide substrates, a related strategy
was used for analysis of BER reaction products. These
oligonucleotide substrates had lesions and sequences
identical to those in the plasmid substrates (Figure 2). In
the case of products formed in reaction mixtures with
labeled dCTP, digestion with XhoI yielded a 32-mer
containing the ﬁrst labeled dCMP incorporated
(Figure 2B), allowing assessment of the molar amount
of product formed. The stalled or unligated BER
Figure 1. Construction of lesion-speciﬁc plasmid substrates. Lesion-
speciﬁc plasmid substrates for in vitro BER assays, pUN1 and pUN2,
were constructed as described under ‘Materials and Methods section’.
The pUC19 was cut with BamHI and a 43-bp fragment was inserted to
create pUC19N that contained two N.BstNB1 sites. Then, the pUC19N
was digested with N.BstNB1 to generate a 48-nt gap. The 48-nt
fragment was removed by hybridizationtoabiotinylated-taggedcomple-
mentary oligonucleotide and followed by adsorption onto streptavidin-
coated magnetic beads. Next, the plasmid, pUN1 or pUN2, was
created by re-hybridization and ligation of gapped pUC19N to the
50-phosphorylated 48-mer oligonucleotide containing either uracil or
THF, respectively, as shown.
e112 Nucleic Acids Research, 2007, Vol. 35, No. 17 PAGE4 OF10intermediate was observed in some cases, and again, this
material was considered as background. The XhoI
digestion also yielded a 23-mer fragment containing the
LP BER incorporations (Figure 2B).
Typical results obtained with a laboratory reference
tissue extract, BTNE, and the plasmid and oligonucleotide
substrates described above are shown in Figure 3. Repair
of the uracil-DNA plasmid substrate and digestion with
KpnI resulted in the labeled 41-mer fragment; very little
stalled 25-mer intermediate was observed (Figure 3A).
In contrast, with the THF-containing plasmid substrate,
a signiﬁcant band representing the stalled intermediate
was observed with KpnI digestion alone (Figure 3A).
This indicated accumulation of the intermediate at the
step just prior to strand displacement synthesis in LP
BER. The results obtained with the oligonucleotide
substrates without restriction enzyme digestion were
similar, except the stalled intermediate was more abun-
dant (Figure 3B).
Double digestion of the plasmid products yielded the
25-mer and 16-mer fragments described above
(Figure 3C). The results illustrated that most of the
uracil-DNA repair corresponded to SN BER, as expected
from earlier results (9). Analysis of the product formed on
the THF-containing oligonucleotide substrate revealed
that the amount of stalled intermediate was greater than
the LP BER product, and with uracil-DNA the results
were similar to those with plasmid substrate (Figure 3D).
Comparison of steady-state kineticfeatures of repair with
plasmid and oligonucleotide substrates
The main goal of this study was to compare kinetic
features of BER product formation with plasmid and
oligonucleotide substrates. We measured the initial rates
of BTNE-mediated BER for the two forms of substrate
under conditions of substrate excess. The rates of product
formation with various uracil-DNA substrate concentra-
tions were linear over the ﬁrst 10min of incubation, as
illustrated at one substrate concentration in the experi-
ment shown in Figure 4. Kinetic features for BTNE-
mediated BER with the two substrates are summarized in
Table 1. The maximal velocities (Vmax) of BER product
formation for the plasmid and oligonucleotide substrates
were similar, but the Km for the plasmid substrate, pUN1,
was slightly higher than that for the oligonucleotide
substrate. The resultant eﬃciency (Vmax/Km) was slightly
higher (3-fold) with the oligonucleotide substrate. These
results indicate that similar rates of uracil-DNA repair can
be obtained with the two forms of substrate, especially
when they are used at concentrations high enough to
support near maximal synthesis, i.e.   Km.
Figure 2. Schematic representation of plasmid and oligonucleotide DNA substrates. (A) Sequence of the uracil-containing fragment of pUN1 and
restriction sites are shown. After the repair reaction, DNA products were restricted with the indicated enzymes, and fragments were separated by
20% denaturing PAGE. DNA fragment sizes and descriptions of DNA synthesis products are indicated. (B) The sequence of 55-bp oligonucleotide
containing uracil at position 32 and a strategic restriction site is shown. The sequence of the oligonucleotide substrate is identical to the 41-mer
fragment of plasmid in (A). DNA fragment sizes and descriptions of DNA synthesis products are indicated.
PAGE 5 OF 10 Nucleic Acids Research, 2007, Vol. 35,No. 17 e112Use ofplasmid substratein measurement of theratio
ofSN to LPBER
In some cases, it is desirable to measure the relative
amounts of the SN and LP BER subpathways. Adjusting
the sequence of the repair patch to eliminate ambiguity
from incorporation of more than one labeled dNMP in
each subpathway can facilitate this measurement.
To accomplish this type of measurement, we constructed
an alternate plasmid substrate termed ‘pPAL1’
(Figure 5A). This plasmid was designed for use in BER
assays along with [a-
32P]dCTP as the labeled nucleotide
substrate. To illustrate use of this method, incubations
were conducted with MEF extract. Double digestion of
the reaction product with NcoI and SacI yielded a 47-mer
representing the entire excision repair patch and a small
amount of stalled intermediate (Figure 5B). Digestion
with these enzymes plus KpnI yielded a 22-mer with the
ﬁrst dNMP incorporated, labeled dCMP, and a 25-mer
with labeled dCMP corresponding to the second nucleo-
tide incorporated and potentially the 25th dCMP incor-
porated into the repair patch (Figure 5A). Since the repair
patch in LP BER is shorter than 25 residues, potential
dCMP incorporation at the 25th position can be ignored.
Therefore, quantiﬁcation of [a-
32P]dCMP incorporated
into the 22-mer and 25-mer fragments, respectively, yields
the molar amounts of total BER product (SN and LP
BER) and LP BER product, as illustrated in Figure 5.
In this case, the ratio of SN BER to LP BER was
approximately 60:40 (Figure 5C), as expected from earlier
results obtained by diﬀerent methods (21,37).
Repair patchanalysis forlong patchbaseexcision repair
products
As noted in Figure 2, the plasmid and oligonucleotide
substrates can be used for repair patch size assessment of
LP BER reaction products. Such analysis involves
restriction enzyme digestion and then the electrophoretic
separation and quantiﬁcation of various labeled fragments
(
32P-labeled dNMP incorporation). Typical results from
this type of analysis are illustrated in Figure 6. In the
experiment shown, we used the THF-containing plasmid,
pUN2, (Figure 1) so that repair corresponded to the LP
BER subpathway only, along with an extract known to be
proﬁcient in LP BER (i.e. from MEFs). Measurement of
dCMP and dTMP incorporated in separate incubations
was conducted (Figure 6). In this case for LP BER, the
amount of dCMP incorporation into the ﬁrst dNMP
position (i.e. 25-mer) is equal to the amount of dTMP
incorporation into the second dNMP position. Therefore,
to evaluate LP BER synthesis beyond the second
Figure 3. Comparison of BER reaction products using plasmid and oligonucleotide substrates. In order to compare the BER reaction products using
plasmid-based or oligonucleotide-based assay, the repair reaction was performed with lesion-speciﬁc DNA substrate, as indicted at the top of each
panel, and BTNE. The reaction conditions and product analyses were as described under ‘Materials and Methods’ section. Panels (A–D), BER
reaction was performed in a 10ml reaction mixture that contained 50nM plasmid/oligonucleotide DNA (uracil- or THF-containing DNA) and 10mg
BTNE. Incubation was for 30min at 378C. The reaction products were puriﬁed, digested with the indicated restriction enzyme (s), and then separated
by 20% denaturing PAGE. Panels (A) and (B) show the total BER products represented by 41-mer and 55-mer DNA fragments obtained with uracil
or THF-containing plasmid, pUN1 or pUN2, and oligonucleotide substrates, respectively. The 25-mer and 32-mer DNA fragments observed with
plasmid and oligonucleotide substrates, respectively, represented unligated or stalled intermediates. Panels (C) and (D), the remaining reaction
products in (A) and (B) were digested with KpnIo rKpnI plus XhoI (Panel C), and XhoI (Panel D), respectively. This resulted in 25-mer (SN BER)
and 16-mer (LP BER) DNA fragments from plasmid substrate and 32-mer (SN BER) and 23-mer (LP BER) DNA fragments from oligonucleotide
substrate, respectively. In cases where unligated or stalled intermediates were observed (i.e. the 25-mer and 32-mer fragments), the counts in these
molecules were considered as background and subtracted for the calculation of SN BER. The positions of total BER, SN BER/stalled and LP BER
products are indicated.
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second position of the 16-mer could be subtracted from
total dTMP incorporation into the 16-mer; this synthesis
in the 16-mer for dTMP incorporation was similar to that
for dCMP incorporation (Figure 6B and C).
Further analysis of repair patch size is illustrated in
Figure 7. Typical results (Figure 7A) and the strategy
for analysis using
32P-labeled dCMP incorporation
(Figure 7B) were as follows: Restriction with KpnI yielded
a 41-nt fragment (41-mer) representing repair patch
synthesis, i.e. from one up to 17 nucleotide incorporations
(Figure 7A, lane 1, and B). With KpnI digestion, some
25-mer BER intermediate was also observed, reﬂecting
stalling at this intermediate. Incorporation of the ﬁrst
nucleotide in the repair patch, dCMP, was measured after
double digestion with KpnI and XhoI, yielding the 25-mer
and the 16-mer (Figure 7A lane 2). The 16-mer fragment
reﬂected three LP BER dCMP incorporations (Figure 7A ,
lane 2, and B). For LP BER synthesis at the 2nd through
7th nucleotides and longer repair patches, respectively, we
measured dCMP incorporation into the corresponding
fragments after double digestions with XhoI and XbaI, i.e.
two fragments (6-mer and 23-mer) as illustrated in
Figure 7 (Figure 7A, lane 3, and B). Incorporation into
the 6-mer was greater than that into the 23-mer, indicating
that most of the LP BER corresponded to repair patches
of 7nt or less (Figure 7C).
DISCUSSION
We made use of a recently acquired method for obtaining
large amounts of plasmid DNA after a preparative in vitro
ligation step (30). A plasmid with a single-strand 48 base
gap was prepared in high yield and in pure enough form to
enable annealing a 48-mer lesion-containing oligonucleo-
tide into the gap. After ligation and puriﬁcation of the
Figure 4. Steady-state kinetic analysis of the repair reaction using
plasmid and oligonucleotide substrates. The reaction conditions and
products analyses were as described under ‘Materials and Methods
section’. Repair reaction was performed under conditions of substrate
excess with BTNE using either uracil-containing plasmid (open circle)
or uracil-containing oligonucleotide (closed circle) substrate. The
concentrations of plasmid and oligonucleotide substrates were 450nM
and 200nM, respectively. Aliquots were taken at the indicated time
intervals, and the DNA products were analyzed as in Figure 3. Time
courses of product formation for the plasmid and oligonucleotide
substrates are shown. BER products were quantiﬁed with ImageQuant
software, and the data were ﬁtted to a straight-line equation. The initial
rates of BTNE-mediated BER for the plasmid and oligonucleotide
substrates were 0.67 and 1.85fmol dCMP incorporated/min, respec-
tively. The experiments were repeated three times, and a representative
graph from one experiment is shown.
Figure 5. Assessment of the ratio of SN to LP BER after repair
incubation. (A) Schematic diagram of uracil-containing plasmid,
‘pPAL1’, is shown. A uracil residue (U) was placed in a central
position of the NcoI/SacI fragment. Three strategic restriction enzyme
sites, NcoI, KpnI and SacI, were designed around the lesion such that
SN and LP BER could be analyzed in the same repair reaction mixture.
After completion of the BER reaction in the presence of [a-
32P]dCTP,
repair products were restricted with either NcoI and SacIo rNcoI, SacI
and KpnI, which generated 47-, 25- and 22-mer DNA fragments
representing total, LP and SN BER products, respectively. To calculate
SN and LP BER products, counts in the 25-mer fragment were
subtracted from the total counts in 22-mer fragment, because for every
incorporation of dCMP at the second position, next to uracil, one
dCMP will be incorporated ﬁrst at the lesion site. (B) pPAL1 (20nM)
was incubated with 10mg of MEF extract in 50mM Tris–HCl, pH 7.5,
5mM MgCl2, 20mM NaCl and 1mM DTT. The reaction was
conducted at 378C for 30min in the presence of 20mM each of
dATP, dGTP, dTTP and 2.3mM[ a-
32P]dCTP. A 16-mer radiolabeled
DNA fragment was added in each reaction mixture as an internal
control prior to phenol/chloroform extraction and ethanol precipita-
tion. The reaction products were analyzed by 15% denaturing PAGE.
The combinations of restriction enzymes used are shown at top of the
PhosphorImager panel. The description of each radiolabeled band is
indicated on the right-hand side of the image. (C) Quantiﬁcation of
total, SN and LP BER is shown in a bar graph. Band intensity of each
radiolabeled DNA fragment, 47-, 25- and 22-mer, was measured in
terms of arbitrary PhosphorImager units and plotted as total BER, SN
BER and LP BER. The experiments were repeated three times and a
PhosphorImage of a representative experiment is shown.
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large amount of DNA was available for use in routine
BER incubations (Figure 1). The availability of such large
quantities of plasmid substrate made it possible for us to
compare steady-state kinetic values for BER obtained
with an oligonucleotide substrate with those obtained with
a plasmid substrate. Such a comparison had been
unresolved and remained an important consideration.
Some investigators maintained that plasmid substrates are
more biologically relevant or useful than oligonucleotide
substrates. On the other hand, others have held the
opposite viewpoint asserting that plasmid substrates are of
limited and specialized use because of the necessity to
employ miniscule concentrations of substrate DNA and
long incubation periods, both of which potentially
confound interpretations on BER capacity measurements.
Our results indicated that the two forms of substrate
yielded similar values for rates of repair in a nuclear
extract, provided the DNA substrate concentration was
high enough in the reaction mixture.
A precaution emerged from the observation that Km for
plasmid substrate was higher than Km for oligonucleotide
substrate. An explanation for this diﬀerence was not
examined. However, on a practical level, when a substrate
excess or steady-state approach is used to quantify
Table 1. Steady-state kinetic measurements of BER using plasmid and
oligonucleotide substrates
Oligonucleotide Plasmid
Km (nM) Vmax
(nM/min)
Vmax/Km
(min
 1 10
 4)
Km
(nM)
Vmax
(nM/min)
Vmax/Km
(min
 1
 10
 4)
51.4 (9.9) 0.05 (0.02) 9.7 (4.3) 216 (27.3) 0.09 (0.03) 4.0 (1.0)
Mean ( SE) of four independent experiments.
Figure 6. Incorporation of labeled dCMP and dTMP into the repair patch produced during LP BER of the THF-containing plasmid. The
repair reaction was performed with THF-containing plasmid, pUN2 and MEF extract. The reaction conditions and product analyses were as
described under ‘Materials and Methods section’. (A) BER reaction was performed in a10ml reaction mixture that contained 20nM pUN2, 10mg
MEF extract and either
32P-dCTP (lanes 1and 2) or
32P-dTTP (lanes 3 and 4). Incubation was for 30min at 378C. The reaction products
were analyzed as in Figure 3. The restriction enzymes used are shown at the top of the PhosphorImager panel. The description of each radiolabeled
band is indicated on both sides of the image. (B) Quantiﬁcation of total BER (41-mer), SN BER (25-mer) and LP BER (16-mer) is shown in a
bar graph. A small portion of each reaction was spotted on the gel ﬁlter for calculations of incorporation of
32P-dCMP or
32P-dTMP in DNA. The
band intensity of each radiolabeled DNA fragment, 41-, 25- and 16-mer, was measured in terms of arbitrary PhosphorImager units and then
converted into relative dCMP or dTMP incorporation. The experiments were repeated three times, and the PhosphorImage of a
representative experiment is shown. (C) The positions of dCMP (ﬁlled circle) or dTMP (cross) incorporation in the 41-, 25- and 16-mer fragments,
and the restriction sites are indicated.
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the two forms of DNA may need to be taken into account.
In addition to characterizing rates of BER as a function
of substrate form, we examined methods for analysis of
repair patch length in the LP BER subpathway. Our initial
experiments in this eﬀort made use of phosphorothioate
dNMP incorporation into the repair patch and subsequent
exonuclease III digestion of products [data not shown,
and ref. (37)]. This approach yielded spurious results (data
not shown). The main diﬃculty stemmed from the
capacity of exonuclease III to digest into the repair
patches containing phosphorothioate dNMPs, leading to
an underestimate of repair patch length. On the other
hand, attempts to reduce the digestion strategically (time
or enzyme concentration) generally lead to an over-
estimate of repair patch length. Therefore, we concluded
that reliable measurements of repair patch length could
not be obtained with this approach. The approach
described here, however, appeared to be reliable and was
limited only by the technical requirements to obtain pure
substrate preparations, restriction digestion of product
molecules to completion, and attention to accurate
quantiﬁcation of the amount of labeled dNMP
incorporated.
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